Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Revealing the Threat of Emerging SARS-CoV-2 Mutations to Antibody Therapies.

Journal of molecular biology - 3 Sept 2021

Chen Jiahui, Gao Kaifu, Wang Rui, Wei Guo-Wei

Abstract excerpt

The ongoing massive vaccination and the development of effective intervention offer the long-awaited hope to end the global rage of the COVID-19 pandemic. However, the rapidly growing SARS-CoV-2 variants might compromise existing vaccines and monoclonal antibody (mAb) therapies. Although there are valuable experimental studies about the potential threats from emerging variants, the results are limited to a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antibodies, Neutralizing
Share to Antibodies, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19

Share to COVID-19 Drug Treatment

Share to Pandemics

Share to SARS-CoV-2

Share to Spike Glycoprotein, Coronavirus

Source

Open in PubMed Open full text

Identifiers

PMID: 34273397
DOI: 10.1016/j.jmb.2021.167155
PMCID: PMC8277955

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Revealing the Threat of Emerging SARS-CoV-2 Mutations to Antibody Therapies.PMID 34273397Read ↗

Revealing the threat of emerging SARS-CoV-2 mutations to antibody therapiesSemantic proximity Read ↗

Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapiesSemantic proximity Read ↗

Emerging Vaccine-Breakthrough SARS-CoV-2 VariantsSemantic proximity Read ↗

Emerging Dominant SARS-CoV-2 VariantsSemantic proximity Read ↗

A High-Resolution Approach to Mapping Spike Protein Evolution for Advancing Antibody Therapy DesignSemantic proximity Read ↗

High-throughput ML-guided design of diverse single-domain antibodies against SARS-CoV-2Semantic proximity Read ↗

Impact of BA.1, BA.2, and BA.4/BA.5 Omicron mutations on therapeutic monoclonal antibodies.Semantic proximity Read ↗

Predicting the immune escape of SARS-CoV-2 neutralizing antibodies upon mutation.Semantic proximity Read ↗

Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor-binding domain.Semantic proximity Read ↗

Genomic mutations and changes in protein secondary structure and solvent accessibility of SARS-CoV-2 (COVID-19 virus).Semantic proximity Read ↗

SARS-CoV-2: lessons in virus mutation prediction and pandemic preparednessSemantic proximity Read ↗

SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and VaccinesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.